1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis prize challenge aims to identify novel biomedical use cases amenable to quantum computing-based solutions, including quantum-classical hybrid solutions.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Multidisciplinary teams (biomedical, quantum scientists, engineers, computational experts). Confirm the full requirements in the official notice before applying.
NIH Quantum Computing Challenge is funded by National Center for Advancing Translational Sciences (NCATS) (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
DOE Genesis Mission SBIR/STTR Phase I Funding Opportunity is sponsored by U.S. Department of Energy (DOE) Office of Technology Commercialization (OTC). This funding opportunity supports small businesses in developing breakthrough technologies that advance DOE's Genesis Mission. The opportunity targets four AI-driven topic areas: biotechnology, quantum computing, materials design, and autonomous laboratories.
DOE Genesis Mission SBIR/STTR Phase I for AI-Driven Biotechnology, Quantum, Materials Design, and Autonomous Laboratories is sponsored by U.S. Department of Energy (DOE) Office of Technology Commercialization. This SBIR/STTR Phase I opportunity provides non-dilutive funding to small businesses across four AI-driven topic areas: biotechnology, quantum computing, materials design, and autonomous laboratories. The program plays a vital role in advancing high-impact research and economic development through non-dilutive funding for American small businesses.
Advance from NIH SBIR Phase I to Phase II with tips on demonstrating feasibility, building a commercialization plan, and securing $1M in funding.
Read articlePAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read article